(Q44216162)

English

Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis

scientific article published in August 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

7

object named as

Henry Eriksson

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Karin Wåhlander

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Leif Lapidus

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Carl-Gustav Olsson

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Anneli Thuresson

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Ulf G Eriksson

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Göran Larson

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Thrombosis Research

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

107

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

3-4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

93-99

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Antithrombotic therapy for venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of the incidence of deep-vein thrombosis within a defined urban population

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of fatal pulmonary embolism in patients with treated venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of revised criteria for ventilation-perfusion scintigraphy in patients with suspected pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of melagatran, a novel, direct thrombin inhibitor, in human plasma and urine by liquid chromatography-mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity: A phase II evaluation. The Rembrandt Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900259-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0049-3848(02)00259-1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44216162&oldid=2143967662"